Terms: = Gastric cancer AND SFRP4, Q6FHJ7, 6424, ENSG00000106483, frpHE, MGC26498, FRPHE, FRP-4 AND Prognosis
4 results:
1. Matrix metalloprotease-14 is a target enzyme for detecting peritoneal metastasis in gastric cancer.
Ogawa S; Kubo H; Murayama Y; Kubota T; Yubakami M; Matsumoto T; Ohashi T; Okamoto K; Kuriki Y; Hanaoka K; Urano Y; Otsuji E
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102420. PubMed ID: 34242818
[TBL] [Abstract] [Full Text] [Related]
2. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract] [Full Text] [Related]
3. Concurrent Hypermethylation of
Wang H; Duan XL; Qi XL; Meng L; Xu YS; Wu T; Dai PG
Mol Cells; 2017 Jan; 40(1):45-53. PubMed ID: 28152305
[TBL] [Abstract] [Full Text] [Related]
4. Development and Validation of a Six-Gene Recurrence Risk Score Assay for gastric cancer.
Lee KW; Lee SS; Hwang JE; Jang HJ; Lee HS; Oh SC; Lee SH; Sohn BH; Kim SB; Shim JJ; Jeong W; Cha M; Cheong JH; Cho JY; Lim JY; Park ES; Kim SC; Kang YK; Noh SH; Ajani JA; Lee JS
Clin Cancer Res; 2016 Dec; 22(24):6228-6235. PubMed ID: 27654712
[TBL] [Abstract] [Full Text] [Related]
